Copertina

Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetes

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ying Wei, Yong Tian, Ruixiang Cui, Ying Wang, Jia Liu, Guang Wang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Diabetes, Obesity and Metabolism
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes
di: Xiaopu Wang, et al.
Pubblicazione: (2024)

Cost‐effectiveness of continuous glucose monitoring in Chinese adults with uncontrolled type 2 diabetes: A modelling study stratified by baseline HbA 1c
di: Guangxin Han, et al.
Pubblicazione: (2025)

CGM ‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes
di: Roland H. Stimson, et al.
Pubblicazione: (2025)

Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes
di: Wolfgang Landgraf, et al.
Pubblicazione: (2025)

Correction to “The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes”
Pubblicazione: (2025)

Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes
di: Jiaqiang Zhang, et al.
Pubblicazione: (2025)

The effect of sodium‐glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM
di: Ran Guo, et al.
Pubblicazione: (2025)

Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial
di: Ying Zhu, et al.
Pubblicazione: (2025)

Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus
di: Moses Yidong Lim, et al.
Pubblicazione: (2026)

Five‐year trajectories of HbA1c by age, sex, ethnicity and deprivation in adults with newly diagnosed type 2 diabetes: Observational study in England
di: Atanu Bhattacharjee, et al.
Pubblicazione: (2025)

Efficacy and hypoglycaemia outcomes of once‐weekly insulin icodec versus once‐daily basal insulin comparators across baseline HbA1c , BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1–5
di: Alice Y. Y. Cheng, et al.
Pubblicazione: (2025)

Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
di: Wanling Lu, et al.
Pubblicazione: (2025)

Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
di: Yongwen Zhou, et al.
Pubblicazione: (2025)

Glucagon‐like peptide‐1 is involved in fasting and postprandial blood flow regulation of subcutaneous adipose tissue
di: Richard Sotorník, et al.
Pubblicazione: (2025)

Distribution of HbA1c Levels in Patients With GCK ‐ MODY : A Worldwide Literature‐Based Retrospective Analysis
di: Yihan Zhao, et al.
Pubblicazione: (2026)

Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c
di: Stephanie L. Samuels, et al.
Pubblicazione: (2024)

HbA1c ≤ 6.5% in Early Type 2 Diabetes: Threshold, Trajectory, or Marker of Integrated Risk Management?
di: Man Sun, et al.
Pubblicazione: (2026)

Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐ O trial
di: Hertzel C. Gerstein, et al.
Pubblicazione: (2024)

Impact of early and tight HbA1c control on the risk of long‐term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register
di: Julie Mount, et al.
Pubblicazione: (2026)

Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
di: Ajenthen G. Ranjan, et al.
Pubblicazione: (2025)

Ethnic variation in the relationship between ectopic fat and insulin resistance: Potential contributions of deep subcutaneous adipose tissue, rs1443512 in HOTAIR , and rs6712203 in COBLL1
di: Francis de Zegher, et al.
Pubblicazione: (2024)

Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
di: Nan Dai, et al.
Pubblicazione: (2024)

Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta‐regression analysis incorporating FLOW and SOUL trials
di: Masashi Hasebe, et al.
Pubblicazione: (2025)

Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes
di: Juan P. Frías, et al.
Pubblicazione: (2025)

Glycaemic impact of the pre‐exercise timing of an elevated glucose target implemented using an automated insulin delivery system in adults with type 1 diabetes
di: Dale J. Morrison, et al.
Pubblicazione: (2025)

Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
di: Pareeta Kotecha, et al.
Pubblicazione: (2024)

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes
di: Mohmmad Alghamdi, et al.
Pubblicazione: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
di: Jia‐Jie Wang, et al.
Pubblicazione: (2024)

Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems
di: Lauren V. Turner, et al.
Pubblicazione: (2024)

Interrelationship Between Baseline HbA1c , SGLT ‐2 Inhibitor Use and Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
di: Samuel Seidu, et al.
Pubblicazione: (2026)

Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes
di: Stephanie A. Hooker, et al.
Pubblicazione: (2026)

Post‐exercise glycaemic control for 24 h: Fasted morning exercise with and without glucagon in adults with type 1 diabetes using automated insulin delivery
di: Clara Solà, et al.
Pubblicazione: (2025)

Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
di: Xianglin Wu, et al.
Pubblicazione: (2025)

Risk of recurrent diabetic ketoacidosis following initiation of sodium‐glucose co‐transporter 2 inhibitors in patients with an insulin‐deficient diabetes and prior diabetic ketoacidosis: An observational cohort study
di: Anat Tsur, et al.
Pubblicazione: (2026)

Effects of insulin‐induced hypoglycaemia on cardiac function in people with type 1 and type 2 diabetes and people without diabetes
di: Therese Wilbek Fabricius, et al.
Pubblicazione: (2025)

Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
di: Irl B. Hirsch, et al.
Pubblicazione: (2024)

Biological aging mediates the associations of metabolic score for insulin resistance with all‐cause and cardiovascular disease mortality among US adults: A nationwide cohort study
di: Xiaoxuan Li, et al.
Pubblicazione: (2024)

Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
di: Howard Wolpert, et al.
Pubblicazione: (2025)

Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes
di: Yaxin Wang, et al.
Pubblicazione: (2024)

No evidence from euglycaemic–hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections—Post hoc meta‐analysis
di: Andrzej S. Januszewski, et al.
Pubblicazione: (2025)